Sector Investment 3 Days

Last updated: August 21, 2026, 10:19 PM ET

Healthcare & Life Sciences

SkyKnight Capital has entered a definitive agreement to invest in Apex Infusion, a specialty infusion services provider, according to a news release. The deal underscores continued private equity appetite for site-of-care businesses as procedures shift out of hospital settings. In another major transaction, Warburg Pincus is leading an investor group to acquire a controlling interest in PANTHERx Rare, a rare-disease pharmacy platform, in a deal valued at $7bn — one of the largest healthcare carve-outs announced this year.

Infrastructure & Real Assets

NPS reported infrastructure assets under management grew 13.4% in 2024, a marked deceleration from the 24.2% pace recorded in 2023, signaling slower capital deployment across the asset class as fund managers compete for a shrinking pool of institutional commitments. Meanwhile, Nvidia and partners have pledged $500bn to back compute as a new investable asset class, but the effort must retain the "infrastructure" element to resonate with pension funds and other long-horizon investors. A separate paper describes a virtuous circle between energy and digital infrastructure, with Nvidia's recent deals with investment managers illustrating the $500bn AI buildout in practice. CIP has reached a $3bn final close for its second growth markets renewables strategy, securing strong support from existing investors despite geopolitical headwinds — a sign that demand for emerging-market clean power remains resilient.